Photodynamic therapy in oral lichen planus: A prospective case-controlled pilot study
Abstract Oral lichen planus (OLP) is a common, chronic relapsing inflammatory disorder of the mucous membranes, which causes major discomfort. Current treatment includes topical/systemic glucocorticoids, immune modulators and systemic immunosuppressants, which may lead to considerable side-effects....
Guardado en:
Autores principales: | , , , , , , , , , , , |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2020
|
Materias: | |
Acceso en línea: | https://doaj.org/article/345a7b4913854b3fb77a11804ebac6cf |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
id |
oai:doaj.org-article:345a7b4913854b3fb77a11804ebac6cf |
---|---|
record_format |
dspace |
spelling |
oai:doaj.org-article:345a7b4913854b3fb77a11804ebac6cf2021-12-02T14:06:51ZPhotodynamic therapy in oral lichen planus: A prospective case-controlled pilot study10.1038/s41598-020-58548-92045-2322https://doaj.org/article/345a7b4913854b3fb77a11804ebac6cf2020-02-01T00:00:00Zhttps://doi.org/10.1038/s41598-020-58548-9https://doaj.org/toc/2045-2322Abstract Oral lichen planus (OLP) is a common, chronic relapsing inflammatory disorder of the mucous membranes, which causes major discomfort. Current treatment includes topical/systemic glucocorticoids, immune modulators and systemic immunosuppressants, which may lead to considerable side-effects. The aim of this study was to determine the clinical and immunological efficacy of photodynamic therapy (PDT) in OLP as an alternative, easy-to-use, safe and non-invasive treatment. Twenty patients with OLP were treated with PDT in a prospective case-controlled pilot-study. PDT was performed on the most extensive oral lesion in 4 sessions (day 1, 3, 7, 14). Peripheral blood and lesional T cells were analysed before (day 1) and after PDT treatment (day 28). PDT led to a statistically significant reduction of clinical parameters (lesion size, ABSIS, Thongprasom-score) and improvement of all evaluated quality-of-life (QOL) items. The clinical improvement was accompanied by a significant decrease of the relative number of CD4+ and CD8+ T cells in mucosal OLP-lesions. Furthermore, CXCL10 plasma levels were decreased and the number of activated peripheral CD4 + CD137+ and CD8 + CD137+ T cells and IL-17-secreting T cells was diminished. PDT treatment in OLP leads to lesion reduction and improvement of QOL, and induces local and systemic anti-inflammatory effects. The study identifies PDT as a novel therapeutic option in OLP.Raluca CosgareaRobert PollmannJusra SharifThomas SchmidtRonja SteinAura BodeaThorsten AuschillAnton SculeanRüdiger EmingBrandon GreeneMichael HertlNicole ArweilerNature PortfolioarticleMedicineRScienceQENScientific Reports, Vol 10, Iss 1, Pp 1-11 (2020) |
institution |
DOAJ |
collection |
DOAJ |
language |
EN |
topic |
Medicine R Science Q |
spellingShingle |
Medicine R Science Q Raluca Cosgarea Robert Pollmann Jusra Sharif Thomas Schmidt Ronja Stein Aura Bodea Thorsten Auschill Anton Sculean Rüdiger Eming Brandon Greene Michael Hertl Nicole Arweiler Photodynamic therapy in oral lichen planus: A prospective case-controlled pilot study |
description |
Abstract Oral lichen planus (OLP) is a common, chronic relapsing inflammatory disorder of the mucous membranes, which causes major discomfort. Current treatment includes topical/systemic glucocorticoids, immune modulators and systemic immunosuppressants, which may lead to considerable side-effects. The aim of this study was to determine the clinical and immunological efficacy of photodynamic therapy (PDT) in OLP as an alternative, easy-to-use, safe and non-invasive treatment. Twenty patients with OLP were treated with PDT in a prospective case-controlled pilot-study. PDT was performed on the most extensive oral lesion in 4 sessions (day 1, 3, 7, 14). Peripheral blood and lesional T cells were analysed before (day 1) and after PDT treatment (day 28). PDT led to a statistically significant reduction of clinical parameters (lesion size, ABSIS, Thongprasom-score) and improvement of all evaluated quality-of-life (QOL) items. The clinical improvement was accompanied by a significant decrease of the relative number of CD4+ and CD8+ T cells in mucosal OLP-lesions. Furthermore, CXCL10 plasma levels were decreased and the number of activated peripheral CD4 + CD137+ and CD8 + CD137+ T cells and IL-17-secreting T cells was diminished. PDT treatment in OLP leads to lesion reduction and improvement of QOL, and induces local and systemic anti-inflammatory effects. The study identifies PDT as a novel therapeutic option in OLP. |
format |
article |
author |
Raluca Cosgarea Robert Pollmann Jusra Sharif Thomas Schmidt Ronja Stein Aura Bodea Thorsten Auschill Anton Sculean Rüdiger Eming Brandon Greene Michael Hertl Nicole Arweiler |
author_facet |
Raluca Cosgarea Robert Pollmann Jusra Sharif Thomas Schmidt Ronja Stein Aura Bodea Thorsten Auschill Anton Sculean Rüdiger Eming Brandon Greene Michael Hertl Nicole Arweiler |
author_sort |
Raluca Cosgarea |
title |
Photodynamic therapy in oral lichen planus: A prospective case-controlled pilot study |
title_short |
Photodynamic therapy in oral lichen planus: A prospective case-controlled pilot study |
title_full |
Photodynamic therapy in oral lichen planus: A prospective case-controlled pilot study |
title_fullStr |
Photodynamic therapy in oral lichen planus: A prospective case-controlled pilot study |
title_full_unstemmed |
Photodynamic therapy in oral lichen planus: A prospective case-controlled pilot study |
title_sort |
photodynamic therapy in oral lichen planus: a prospective case-controlled pilot study |
publisher |
Nature Portfolio |
publishDate |
2020 |
url |
https://doaj.org/article/345a7b4913854b3fb77a11804ebac6cf |
work_keys_str_mv |
AT ralucacosgarea photodynamictherapyinorallichenplanusaprospectivecasecontrolledpilotstudy AT robertpollmann photodynamictherapyinorallichenplanusaprospectivecasecontrolledpilotstudy AT jusrasharif photodynamictherapyinorallichenplanusaprospectivecasecontrolledpilotstudy AT thomasschmidt photodynamictherapyinorallichenplanusaprospectivecasecontrolledpilotstudy AT ronjastein photodynamictherapyinorallichenplanusaprospectivecasecontrolledpilotstudy AT aurabodea photodynamictherapyinorallichenplanusaprospectivecasecontrolledpilotstudy AT thorstenauschill photodynamictherapyinorallichenplanusaprospectivecasecontrolledpilotstudy AT antonsculean photodynamictherapyinorallichenplanusaprospectivecasecontrolledpilotstudy AT rudigereming photodynamictherapyinorallichenplanusaprospectivecasecontrolledpilotstudy AT brandongreene photodynamictherapyinorallichenplanusaprospectivecasecontrolledpilotstudy AT michaelhertl photodynamictherapyinorallichenplanusaprospectivecasecontrolledpilotstudy AT nicolearweiler photodynamictherapyinorallichenplanusaprospectivecasecontrolledpilotstudy |
_version_ |
1718391954202427392 |